Lateral size of graphene oxide determines differential cellular uptake and cell death pathways in Kupffer cells, LSECs, and hepatocytes
Source abstract
Abstract
As a representative two-dimensional (2D) nanomaterial, graphene oxide (GO) has shown high potential in many applications due to its large surface area, high flexibility, and excellent dispersibility in aqueous solutions. These properties make GO an ideal candidate for bio-imaging, drug delivery, and cancer therapy. When delivered to the body, GO has been shown to accumulate in the liver, the primary accumulation site of systemic delivery or secondary spread from other uptake sites, and induce liver toxicity. However, the contribution of the GO physicochemical properties and individual liver cell types to this toxicity is unclear due to property variations and diverse cell types in the liver. Herein, we compare the effects of GOs with small (GO-S) and large (GO-L) lateral sizes in three major cell types in liver, Kupffer cells (KCs), liver sinusoidal endothelial cells (LSECs), and hepatocytes. While GOs induced cytotoxicity in KCs, they induced significantly less toxicity in LSECs and hepatocytes. For KCs, we found that GOs were phagocytosed that triggered NADPH oxidase mediated plasma membrane lipid peroxidation, which leads to PLC activation, calcium flux, mitochondrial ROS generation, and NLRP3 inflammasome activation. The subsequent caspase-1 activation induced IL-1β production and GSDMD-mediated pyroptosis. These effects were lateral size-dependent with GO-L showing stronger effects than GO-S. Amongst the liver cell types, decreased cell association and the absence of lipid peroxidation resulted in low cytotoxicity in LSECs and hepatocytes. Using additional GO samples with different lateral sizes, surface functionalities, or thickness, we further confirmed the differential cytotoxic effects in liver cells and the major role of GO lateral size in KUP5 pyroptosis by correlation studies. These findings delineated the GO effects on cellular uptake and cell death pathways in liver cells, and provide valuable information to further evaluate GO effects on the liver for biomedical applications.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Neonatal Health and Biochemistry · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (68)
Show source-provided references
1. Metal–organic layers as multifunctional two-dimensional nanomaterials for enhanced photoredox catalysis10.1021/jacs.9b08956 ↗
2. Catalysis with two-dimensional materials confining single atoms: concept, design, and applications
3. Multifunctional cellular materials based on 2D nanomaterials: prospects and challenges10.1002/adma.201704850 ↗
4. Noncovalent functionalization of graphene and graphene oxide for energy materials, biosensing, catalytic, and biomedical applications10.1021/acs.chemrev.5b00620 ↗
5. Graphene: status and prospects10.1126/science.1158877 ↗
6. Chemical functionalization and characterization of graphene-based materials10.1039/C7CS00229G ↗
7. Graphene oxide membranes: functional structures, preparation and environmental applications10.1016/j.nantod.2018.04.007 ↗
8. Recent progresses in graphene based bio-functional nanostructures for advanced biological and cellular interfaces10.1016/j.nantod.2019.03.003 ↗
9. Graphene-based drug delivery systems in tissue engineering and nanomedicine10.1139/cjpp-2018-0225 ↗
10. Rolled graphene oxide foams as three-dimensional scaffolds for growth of neural fibers using electrical stimulation of stem cells10.1016/j.carbon.2015.06.079 ↗
11. Identification and optimization of carbon radicals on hydrated graphene oxide for ubiquitous antibacterial coatings10.1021/acsnano.6b05692 ↗
12. Glowing graphene quantum dots and carbon dots: properties, syntheses, and biological applications10.1002/smll.201402648 ↗
13. Can graphene take part in the fight against COVID-1910.1016/j.nantod.2020.100883 ↗
14. Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy10.1016/j.jconrel.2018.07.034 ↗
15. Promises, facts and challenges for graphene in biomedical applications10.1039/C7CS00363C ↗
16. Nanoparticle–liver interactions: cellular uptake and hepatobiliary elimination10.1016/j.jconrel.2016.01.020 ↗
17. Accumulation and toxicity of intravenously-injected functionalized graphene oxide in mice: accumulation and toxicity of functionalized graphene oxide in mice10.1002/jat.3187 ↗
18. Graphene oxide causes disordered zonation due to differential intralobular localization in the liver10.1021/acsnano.9b08127 ↗
19. Crucial role of lateral size for graphene oxide in activating macrophages and stimulating pro-inflammatory responses in cells and animals10.1021/acsnano.5b04751 ↗
20. Size-dependent cell uptake of protein-coated graphene oxide nanosheets10.1021/am300253c ↗
21. Kupffer cells in the liver10.1002/j.2040-4603.2013.tb00510.x ↗
22. The mononuclear phagocyte system10.1016/j.coi.2005.11.008 ↗
23. All roads lead to the liver: metal nanoparticles and their implications for liver health10.1002/smll.202000153 ↗
24. Mechanism of hard-nanomaterial clearance by the liver10.1038/nmat4718 ↗
25. Surface oxidation of graphene oxide determines membrane damage, lipid peroxidation, and cytotoxicity in macrophages in a pulmonary toxicity model10.1021/acsnano.7b07737 ↗
26. Large-sized graphene oxide synergistically enhances parenchymal hepatocyte IL-6 expression monitored by dynamic imaging10.1039/C9NR10713D ↗
27. Graphene oxide induces toll-like receptor 4 (TLR4)-dependent necrosis in macrophages10.1021/nn402330b ↗
28. Toxicological profiling of metal oxide nanoparticles in liver context reveals pyroptosis in Kupffer cells and macrophages versus apoptosis in hepatocytes10.1021/acsnano.8b01086 ↗
29. Mechanistic differences in cell death responses to metal‐based engineered nanomaterials in Kupffer cells and hepatocytes
30. Liver sinusoidal endothelial cells10.1002/j.2040-4603.2015.tb00660.x ↗
31. Fluid phase endocytosis of [125 I]iodixanol in rat liver parenchymal, endothelial and Kupffer cells10.1007/s004410100348 ↗
32. Structural and functional hepatocyte polarity and liver disease10.1016/j.jhep.2015.06.015 ↗
33. Liver sinusoidal endothelial cells: physiology and role in liver diseases10.1016/j.jhep.2016.07.009 ↗
34. Graphene oxide induces apoptotic cell death in endothelial cells by activating autophagy via calcium-dependent phosphorylation of c-Jun N-terminal kinases10.1016/j.actbio.2016.09.018 ↗
35. Use of polymeric nanoparticle platform targeting the liver to induce treg-mediated antigen-specific immune tolerance in a pulmonary allergen sensitization model10.1021/acsnano.9b01444 ↗
36. A systems toxicology approach to the surface functionality control of graphene–cell interactions10.1016/j.biomaterials.2013.09.108 ↗
37. Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung10.1021/nl202515a ↗
38. Manipulation and quantification of graphene oxide flake size: photoluminescence and cytotoxicity10.1021/acsami.7b08585 ↗
39. Systematic toxicity investigation of graphene oxide: evaluation of assay selection, cell type, exposure period and flake size10.1039/C7TX00278E ↗
40. Endocytic mechanisms of graphene oxide nanosheets in osteoblasts, hepatocytes and macrophages10.1021/am5031598 ↗
41. Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition10.1016/j.cell.2011.06.025 ↗
42. NADPH oxidase-dependent NLRP3 inflammasome activation and its important role in lung fibrosis by multiwalled carbon nanotubes10.1002/smll.201402859 ↗
43. Diphenyleneiodonium chloride, an inhibitor of reduced nicotinamide adenine dinucleotide phosphate oxidase, suppresses light-dependent induction of clock and DNA repair genes in zebrafish10.1248/bpb.34.1343 ↗
44. Lipid peroxidation is essential for phospholipase C activity and the inositol-trisphosphate-related Ca2+ signal
45. Lipid peroxidation drives gasdermin D-mediated pyroptosis in lethal polymicrobial sepsis10.1016/j.chom.2018.05.009 ↗
46. Protein corona-mediated mitigation of cytotoxicity of graphene oxide10.1021/nn200021j ↗
47. Protein corona mitigates the cytotoxicity of graphene oxide by reducing its physical interaction with cell membrane10.1039/C5NR01839K ↗
48. Surface interactions with compartmentalized cellular phosphates explain rare earth oxide nanoparticle hazard and provide opportunities for safer design10.1021/nn406166n ↗
49. Pyroptosis versus necroptosis: similarities, differences, and crosstalk10.1038/s41418-018-0212-6 ↗
50. The mechanisms of graphene-based materials-induced programmed cell death: a review of apoptosis, autophagy, and programmed necrosis10.2147/IJN.S140526 ↗
51. Interactions of graphene with mammalian cells: molecular mechanisms and biomedical insights10.1016/j.addr.2016.08.009 ↗
52. The role of NADPH oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts10.3389/fphys.2016.00017 ↗
53. NADPH oxidase in the liver: defensive, offensive, or fibrogenic10.1053/j.gastro.2006.05.048 ↗
54. Lipid peroxidation adds fuel to Pyr(optosis)10.1016/j.chom.2018.06.010 ↗
55. Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis10.1038/ncomms7201 ↗
56. Mitochondrial regulation of store-operated calcium signaling in T lymphocytes10.1083/jcb.137.3.633 ↗
57. Critical role for calcium mobilization in activation of the NLRP3 inflammasome10.1073/pnas.1117765109 ↗
58. Calcium signaling and mitochondrial destabilization in the triggering of the NLRP3 inflammasome10.1016/j.it.2014.02.007 ↗
59. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation10.1038/s41586-018-0372-z ↗
60. Pyroptosis: host cell death and inflammation10.1038/nrmicro2070 ↗
61. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death10.1038/nature15514 ↗
62. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores10.1038/nature18629 ↗
63. Live imaging of label-free graphene oxide reveals critical factors causing oxidative-stress-mediated cellular responses10.1021/acsnano.7b07734 ↗
64. Graphene microsheets enter cells through spontaneous membrane penetration at edge asperities and corner sites10.1073/pnas.1222276110 ↗
65. Role of target geometry in phagocytosis10.1073/pnas.0600997103 ↗
66. Toxic potential of materials at the nanolevel10.1126/science.1114397 ↗
67. Physico-chemical properties based differential toxicity of graphene oxide/reduced graphene oxide in human lung cells mediated through oxidative stress10.1038/srep39548 ↗
68. Cytokine profiling of primary human macrophages exposed to endotoxin-free graphene oxide: size-independent NLRP3 inflammasome activation10.1002/adhm.201700815 ↗